BiotechTube

Sugammadex + Rocuronium

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anesthesia, General

Conditions

Anesthesia, General

Trial Timeline

Oct 27, 2005 โ†’ Sep 9, 2006

NCT ID
NCT00475215

About Sugammadex + Rocuronium

Sugammadex + Rocuronium is a phase 3 stage product being developed by Merck for Anesthesia, General. The current trial status is completed. This product is registered under clinical trial identifier NCT00475215. Target conditions include Anesthesia, General.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (5)

NCT IDPhaseStatus
NCT02484651ApprovedCompleted
NCT02451202ApprovedCompleted
NCT00656799Phase 3Completed
NCT00475215Phase 3Completed
NCT00298831Phase 3Completed

Competing Products

20 competing products in Anesthesia, General

See all competitors
ProductCompanyStageHype Score
Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofolEisaiApproved
85
arm 1 + LUSEDRA + Propofol (arm 3)EisaiPhase 1
33
Remimazolam Tosilate for InjectionJiangsu Hengrui MedicinePre-clinical
23
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
77
Remimazolam TosylateJiangsu Hengrui MedicinePhase 1
33
HR020602 injection + fentanyl injection ๏ผ› remifentanil injectionJiangsu Hengrui MedicinePhase 2
52
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 2
52
Remimazolam Tosilate + Propofol Injection.Jiangsu Hengrui MedicinePhase 2
52
Ropivacaine + BupivacaineAstraZenecaPhase 3
77
SugammadexMerckPhase 2
52
SugammadexMerckPhase 2
52
Sugammadex + neostigmineMerckPhase 3
77
Sugammadex + Rocuronium + Sevoflurane + PropofolMerckPhase 3
77
Rocuronium + Sugammadex + Neostigmine + AtropineMerckPhase 3
77
Rocuronium 0.6 mg/kg intubating dose + Rocuronium 0.9 mg/kg intubating dose + Rocuronium 0.1 mg/kg maintenance dose + Rocuronium 0.15 mg/kg maintenance dose + Rocuronium 0.2 mg/kg maintenance + Vecuronium 0.1 mg/kg intubating dose + Vecuronium 0.025 mg/kg maintenance doseMerckPhase 3
77
Rocuronium bolus maintenance + rocuronium continuous infusion maintenanceMerckPhase 3
77
Sugammadex + NeostigmineMerckPhase 3
77
sugammadexMerckPhase 3
77
Sugammadex + Succinylcholine + RocuroniumMerckPhase 3
77
Rocuronium bromide + Rocuronium bromide + Rocuronium bromide + Sevoflurane + PropofolMerckPhase 3
77

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
MavencladยฎApproved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85